Schedule 13G ownership disclosure
Stoke Therapeutics Inc
Common Stock, $0.0001 par value per share · CUSIP: 86150R107
Event date: 2025-09-30
- Filing-level shares
- 0
- Percent of class
- 0%
- Cowen Financial Products LLC
Shares: 0 · Class: 0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001771015-25-000011
- Form type
- SCHEDULE 13G/A
- Filer
- Cowen Financial Products LLC
- CIK
- CIK 1771015
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership